Solanezumab does not slow cognitive decline in preclinical Alzheimer disease
For patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in the New England Journal of Medicine to coincide with the annual Alzheimer's Association ...
Jul 19, 2023
0
1